Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis.
Elisabeth
E
Mazoyer
Jean-Philippe
JP
Kevorkian
Elisabeth
E
Biyick
Sylvia
S
Bellucci
Catherine
C
Michalski
Ludovic
L
Drouet
D000787:Angina Pectoris / Q000097:blood / Q000150:complications; D016063:Blood Loss, Surgical / Q000517:prevention & control; D023921:Coronary Stenosis / Q000097:blood / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004341:Drug Evaluation; D005167:Factor VII / Q000008:administration & dosage / Q000627:therapeutic use*; D005168:Factor VII Deficiency / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D006044:Goiter, Nodular / Q000150:complications / Q000601:surgery; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011292:Premedication; D012307:Risk Factors; D012907:Smoking / Q000097:blood; D019851:Thrombophilia / Q000150:complications*; D013965:Thyroidectomy
D005167:Factor VII